Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    elad
Show Display Options
Rank Status Study
1 Withdrawn Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)
Condition: Fulminant Hepatic Failure
Interventions: Other: Standard of Care;   Device: ELAD®
2 Completed Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency
Conditions: Acute Hepatitis;   Chronic Hepatitis
Interventions: Biological: ELAD plus standard of care treatment;   Other: Standard of care treatment
3 Recruiting Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
Condition: Acute Alcoholic Hepatitis
Interventions: Biological: ELAD  treatment;   Other: Standard of care (Control)
4 Recruiting A Study to Assess Safety and Efficacy of ELAD in Severe Acute Alcoholic Hepatitis Steroid Failures
Condition: Severe Acute Alcoholic Hepatitis
Interventions: Biological: ELAD;   Other: Standard of Care treatment
5 Recruiting Safety and Efficacy of ELAD to Treat Acute Liver Failure (ALF)
Conditions: Acute Liver Failure;   Fulminant Hepatic Failure;   Primary Graft Non-Function;   Surgically-Induced Liver Failure
Intervention: Biological: ELAD
6 Completed Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis
Condition: Acute On Chronic Hepatitis
Interventions: Biological: ELAD plus standard of care treatment;   Other: Standard of care
7 Completed Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure
Condition: Fulminant Hepatic Failure
Interventions: Biological: ELAD;   Other: Standard of care (Control)
8 No longer available Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery
Condition: Liver Failure
Intervention: Device: ELAD®
9 Recruiting Evaluating Liraglutide in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Liraglutide;   Drug: Placebo
10 Withdrawn Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion
Condition: Acute Liver Failure
Intervention: Drug: ELAD (Extracorporeal Liver Assist System)
11 Unknown  Postconditioning in Primary PCI and Direct Stenting
Condition: Myocardial Infarction
Intervention: Procedure: Postconditioning
12 Unknown  Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients
Condition: Xerostomia
Intervention: Behavioral: hypnosis
13 Unknown  Premature Rupture of Mambrane and Unfavourable Cervix
Condition: Cervix; Insufficient Dilatation in Labor
Interventions: Device: COOK RIPENENIG BALLOON+PITOCN;   Drug: PITOCIN;   Other: double balloonand oxytocin;   Other: ballon and oxytocin;   Procedure: double balloonand and oxytocin
14 Completed Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography
Conditions: Atrial Fibrillation;   Atrial Flutter
Intervention: Device: Intracardiac Imaging
15 Unknown  Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.
Condition: Chronic Hepatitis C
Intervention: Drug: omega-3 fatty acid
16 Recruiting The Effect of Complementary Medicine (CAM) Treatments on Common Symptoms in Hospitalized Patients
Conditions: Pain;   Nausea;   Anxiety
Intervention: Other: CAM treatments
17 Unknown  Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Condition: Stroke
Interventions: Drug: Anti-platelets and statin;   Drug: alteplase;   Procedure: intra arterial intervention
18 Unknown  Women's Involvement In Decision Making At Labor And Its Effect on Their Perceived Labor Process
Condition: Mother (Person)
Intervention:
19 Unknown  The Role of Pro-angiogenic Immune Cells in Human Pregnancies
Conditions: Fetal Growth Retardation;   Preeclampsia
Intervention: Other: Biological specimen
20 Recruiting Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)
Condition: Oral Chronic Graft vs Host Disease
Interventions: Drug: Budesonide;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years